QUT ePrints

Browse By Person: Doggrell, Sheila

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 161.

Book

Doggrell, Sheila, Davis, Elizabeth, Hart, Joanne, Hinton, Tina, Johnson, Graham, & Mullaney, Ian (2012) Pharmacology in one semester. Sheila Doggrell.
Number of full-text downloads 413

Book Chapter

Doggrell, Sheila & Davis, Elisabeth (2012) Anti-infectives. In Doggrell, Sheila (Ed.) Pharmacology in One semester.
Number of full-text downloads 77

Doggrell, Sheila (2012) Drug development. In Phamacology in one semester. Doggrell, Sheila.
Number of full-text downloads 41

Doggrell, Sheila (2012) Drug distribution, metabolism and elimination, and relationship to blood levels. In Doggrell, Sheila (Ed.) Pharmacology in one semester. eBook.
Number of full-text downloads 89

Doggrell, Sheila & Hart, Joaane L. (2012) Drugs Used to Treat Endocrine Disorders. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 143

Doggrell, Sheila (2012) Drugs and the autonomic nervous system. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 116

Doggrell, Sheila (2012) Drugs and the respiratory system. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 141

Doggrell, Sheila (2012) Introduction to pharmacology, and routes of drug administration. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Sheila Doggrell.
Number of full-text downloads 304

Doggrell, Sheila (2012) Neurological drugs and opioids for pain management. In Doggrell, Sheila (Ed.) Pharmacology in One semester.
Number of full-text downloads 77

Doggrell, Sheila (2012) Pharmacodynamics. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
Number of full-text downloads 75

Doggrell, Sheila (2012) Pharmacovigilance and pharmacogenetics. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
Number of full-text downloads 72

Doggrell, Sheila (2012) Poisoning with drugs. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
Number of full-text downloads 35

Doggrell, Sheila (2012) Smoking cessation. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 52

Journal Article

Doggrell, Sheila A. & Tuli, Rinku (2014) Dapagliflozin – do we need it registered for type 2 diabetes? Expert Opinion on Pharmacotherapy, 15(11), pp. 1631-1635.

Doggrell, Sheila A (2014) Not so critical appraisal of dapagliflozin. Patient Preference and Adherence, 8, pp. 1101-1104.
Number of full-text downloads 11

Doggrell, S. A. & Chan, V. (2014) Do interventions by allied health professionals discussing adherence to insulin improve this adherence? Diabetes research and clinical practice, 104(3), e61-e63.
Number of full-text downloads 4

Doggrell, Sheila & Warot, Servane (2014) The association between the measurement of adherence to anti-diabetes medicine and the HbA1c. International journal of clinical pharmacy, 36(3), pp. 488-497.

Doggrell, Sheila A. & Dimmitt, Simon B. (2014) Gliptins - do they increase cardiovascular risk or benefit? Expert opinion in drug safety, 13(5), pp. 675-680.

Doggrell, Sheila A. (2014) Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin. Patient Preference and Adherence, 2014(8), pp. 473-475.
Number of full-text downloads 3
Number of citations in Web of Science® 1

Doggrell, Sheila & McIntyre, Kerry (2014) Canagliflozin : something new for type 2 diabetes, but is it safe and efficacious? Expert Opinion on Pharmacotherapy, 15(3), pp. 437-441.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila A & Hancox, Jules C (2014) Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine. Expert Opinion on Drug Safety, 13(1), pp. 131-138.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila & Kairuz, Therese (2014) Comparative studies of how living circumstances influence medication adherence in >65 year olds. International Journal of Clinical Pharmacy, 36(1), pp. 30-35.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila Anne (2013) Comment on: Clinical benefits of ezetimibe : absence of proof is just that. Expert Opinion on Pharmacotherapy, 14(18), pp. 2611-2613.
Number of full-text downloads 20

Doggrell, Sheila Anne (2013) Inadequate management of medicines by the older-aged living in a retirement village. International Journal of Clinical Pharmacy, 35(4), pp. 546-549.
Number of full-text downloads 1
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila A & Hancox, Jules C (2013) Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia. Expert Opinion on Drug Safety, 12(3), pp. 421-431.
Number of full-text downloads 22
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila A (2013) Exenatide extended-release; clinical trials, patient preference, and economic considerations. Patient Preference and Adherence, 7, pp. 35-45.
Number of full-text downloads 82
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila Anne & Chan, Vincent (2012) Bariatric surgery or medicine for type 2 diabetes? Expert Opinion on Pharmacotherapy, 13(15), pp. 2249-2253.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2012) Dalcetrapib restoring belief in modulating CETP as a beneficial mechanism in cardiovascular disease. Expert Opinion in Investigational Drugs, 21(4), pp. 569-573.
Number of full-text downloads 73
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila & Kairuz, Therese (2012) Medicine management by the older-aged living independently in different types of retirement villages. Journal of Pharmacy Practice and Research, 42, pp. 208-212.
Number of full-text downloads 99
Number of citations in Scopus 2

Doggrell, Sheila (2011) Adherence to oral endocrine treatments in women with breast cancer: can it be improved? Breast Cancer Research and Treatment, 129(2), pp. 299-308.
Number of citations in Scopus 7
Number of citations in Web of Science® 6

Doggrell, Sheila & Christensen, Anne-Marie (2011) Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Expert Opinion on Pharmacotherapy, 12(1), pp. 157-163.
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2011) Bitter taste receptors as a target for bronchodilation. Expert Opinion on Therapeutic Targets, 15(7), pp. 899-902.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2011) CX3CR1 as a target for airways inflammation. Expert Opinion on Therapeutic Targets, 15(9), pp. 1139-1142.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2011) Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease? Reviews on Recent Clinical Trials, 6(2), pp. 147-157.
Number of citations in Scopus 2

Doggrell, Sheila (2011) Lemur tyrosine kinase-3 (LMTK3) as a target in oestrogen positive breast cancer. Expert Opinion on Therapeutic Targets, 15(12), pp. 1419-1422.

Doggrell, Sheila (2011) Lowering LDL cholesterol with margarine containing plant stanol/sterol esters: Is it still relevant in 2011? Complementary Therapies in Medicine, 19(1), pp. 37-46.
Number of citations in Scopus 6
Number of citations in Web of Science® 4

Doggrell, Sheila (2011) Sitagliptin or exenatide once weekly for type 2 diabetes: Comparison of the clinical trials. Expert Opinion on Pharmacotherapy, 12(13), pp. 2055-2067.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2011) Treatment for relapsed Hodgkin lymphoma: Refinement of chemotherapy or targeted treatment? Expert Opinion on Pharmacotherapy, 12(6), pp. 991-994.

Doggrell, Sheila (2011) A new approach to Parkinson's disease: inhibition of leucine-rich repeat kinase-2. Expert Opinion on Investigational Drugs: authoritative analysis of R&D trends, 20(4), pp. 587-590.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila Anne (2010) Resolvin inflammation with pain. Expert Opinion on Investigational Drugs, 19(11), pp. 1461-1464.
Number of full-text downloads 101
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila Anne (2010) Oral fingolimod for relapsing-remitting multiple sclerosis. Expert Opinion on Pharmacotherapy, 11(10), pp. 1777-1781.
Number of full-text downloads 14
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2010) Zoledronic acid once-yearly : what role in the prevention of non-vertebral osteoporotic fractures? Clinical Medicine Insights: Therapeutics, 2010(2), pp. 539-547.
Number of full-text downloads 317

Doggrell, Sheila Anne (2010) The hedgehog pathway inhibitor GDC-0449 shows potential in skin and other cancers. Expert Opinion on Investigational Drugs, 19(3), pp. 451-454.
Number of full-text downloads 175
Number of citations in Scopus 9
Number of citations in Web of Science® 8

Doggrell, Sheila (2010) Does intervention by an allied health professional discussing adherence to medicines improve this adherence in Type 2 diabetes? Diabetic Medicine: journal of diabetes UK, 27(12), pp. 1341-1349.
Number of citations in Scopus 2

Doggrell, Sheila Anne & Christensen, Anne-Marie (2010) Does the p38 MAP kinase inhibitor pamapimod have potential for the treatment of rheumatoid arthritis? Expert Opinion on Pharmacotherapy, 11(14), pp. 2437-2442.
Number of full-text downloads 95
Number of citations in Scopus 1

Doggrell, Sheila (2010) New drugs for the treatment of coronary artery syndromes. Expert Opinion on Pharmacotherapy, 11(2), pp. 325-329.
Number of full-text downloads 171

Hancox, Jules & Doggrell, Sheila (2010) Perspective: Does ranolazine have potential for the treatment of atrial fibrillation? Expert Opinion on Investigational Drugs, 19(12), pp. 1465-1474.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2009) Is liraglutide or exenatide better in type 2 diabetes? Expert Opinion on Pharmacotherapy, 10(16), pp. 2769-2772.
Number of full-text downloads 489
Number of citations in Scopus 2

Doggrell, Sheila (2009) Anti-cancer activity of zoledronic acid in breast cancer. Expert Opinion on Pharmacotherapy, 10(14), pp. 2387-2390.

Doggrell, Sheila (2009) Clinical efficacy and safety of zoledronic acid in osteoporosis and Paget's disease. Expert Review of Endocrinology and Metabolism, 4(5), pp. 405-415.

Doggrell, Sheila (2009) Clinical efficacy and safety of zoledronic acid in prostate and breast cancer. Expert Review of Anticancer Therapy, 9(9), pp. 1211-1218.
Number of full-text downloads 263
Number of citations in Scopus 10
Number of citations in Web of Science® 7

Doggrell, Sheila (2009) Good clinical endpoints with denosumab in osteoporosis and cancer. Expert Opinion in Pharmacotherapy, 10(17), pp. 2939-2943.
Number of full-text downloads 131

Doggrell, Sheila (2009) Lyprinol : is it a useful anti-inflammatory agent? Evidence Based Complementary and Alternative Medicine.
Number of full-text downloads 434
Number of citations in Scopus 3

Doggrell, Sheila (2009) New findings with old drugs for osteoporosis. Expert Opinion on Pharmacotherapy, 10(3), pp. 513-516.
Number of full-text downloads 132
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2009) Telcagepant is a new oral treatment for migraine. Expert Opinion in Pharmacotherapy, 10(9), pp. 1523-1526.
Number of full-text downloads 193
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila (2009) Tesofensine : a novel potent weight loss medicine. Expert Opinion in Investigational Drugs, 18(7), pp. 1043-1046.
Number of full-text downloads 233
Number of citations in Scopus 6
Number of citations in Web of Science® 5

Doggrell, Sheila (2008) What is the future for rimonabant in the treatment of obesity. Review of Endocrinology, December, pp. 14-17.

Doggrell, Sheila (2008) Celecoxib to prevent restenosis - results from the COREA-TAXUS trial. Expert Opinion on Pharmacotherapy, 9(2), pp. 339-341.

Doggrell, Sheila (2008) Clinical trials with thiazolidinediones in subjects with Type 2 diabetes - is pioglitazone any different from rosiglitazone? Expert Opinion on Pharmacotherapy, 9(3), pp. 405-420.
Number of citations in Scopus 14
Number of citations in Web of Science® 11

Doggrell, Sheila (2008) Is long-term adjuvant treatment of breast cancer with anastrozole indicated? Expert Opinion on Pharmacotherapy, 9(9), pp. 1619-1622.
Number of citations in Scopus 3
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) Is rimonabant efficacious and safe in the treatment of obesity? Expert Opinion on Pharmacotherapy, 9(15), pp. 2727-2731.
Number of citations in Scopus 15
Number of citations in Web of Science® 14

Doggrell, Sheila (2008) Is sapropterin treatment suitable for all subjects with phenylketonuria? Expert Opinion on Pharmacotherapy, 9(1), pp. 145-147.
Number of citations in Scopus 5
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) Is tocilizumab an option for the treatment of arthritis? Expert Opinion on Pharmacotherapy, 9(11), pp. 2009-2013.

Doggrell, Sheila (2008) New indications for topiramate: alcohol dependency and binge-eating disorder. Expert Opinion on Pharmacotherapy, 9(5), pp. 869-873.
Number of citations in Scopus 3
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) Therapeutic potential of non-peptide chymase inhibitors. Expert Opinion on Therapeutic Patents, 18(5), pp. 485-499.
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila (2007) Cardiovascular and renal effects of nociceptin/orphanin FQ: a new mediator to target? Current Opinion in Investigational Drugs, 8(9), pp. 742-749.
Number of citations in Scopus 5
Number of citations in Web of Science® 5

Doggrell, Sheila (2007) Clopidogrel use with stenting. Expert Opinion on Pharmacotherapy, 8(9), pp. 1399-1402.
Number of citations in Scopus 1
Number of citations in Web of Science® 2

Doggrell, Sheila (2007) Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction? International Journal of Impotence Research, 19(3), pp. 281-295.
Number of citations in Scopus 21
Number of citations in Web of Science® 13

Doggrell, Sheila (2007) Does rosiglitazone increase cardiovascular outcomes? Expert Opinion on Pharmacotherapy, 8(15), pp. 2665-2669.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2007) Is fingolimod an advancement in the treatment of multiple sclerosis? Expert Opinion on Pharmacotherapy, 8(3), pp. 383-386.
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2007) Misoprostol for the treatment of early pregnancy failure. Current Clinical Pharmacology, 2(1), pp. 1-9.
Number of citations in Scopus 3

Doggrell, Sheila (2007) Novel drugs and products in neuroscience: highlights from IBRO. Drugs of the Future, 32(11), pp. 1007-1017.

Doggrell, Sheila (2007) Rosiglitazone: rosy news for a thiazolidinedione. Expert Opinion on Pharmacotherapy, 8(2), pp. 265-268.
Number of citations in Scopus 1

Doggrell, Sheila (2006) After the failure of citalopram for depression, what next? Expert Opinion on Pharmacotherapy, 7(11), pp. 1515-1518.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2006) Bradykinin B2 receptors as a target in diabetic nephropathy. Current Opinion in Investigational Drugs, 7(3), pp. 251-255.
Number of citations in Scopus 4

Doggrell, Sheila (2006) Ceramide as a target in emphysema. Expert Opinion on Therapeutic Targets, 10(1), pp. 191-194.

Doggrell, Sheila (2006) Inhibition of RANKL: a new approach to the treatment of osteoporosis. Expert Opinion on Pharmacotherapy, 7(8), pp. 1097-1100.
Number of citations in Scopus 2

Doggrell, Sheila (2006) Inhibitors of cholesteryl ester transfer protein - a new approach to coronary artery disease. Expert Opinion on Investigational Drugs, 15(2), pp. 99-106.
Number of citations in Scopus 16
Number of citations in Web of Science® 11

Doggrell, Sheila (2006) Is NXY-059 an advancement in the treatment of acute ischaemic stroke? Expert Opinion on Pharmacotherapy, 7(7), pp. 965-968.

Doggrell, Sheila (2006) Is amlodipine the best initial monotherapy for hypertension? Expert Opinion on Pharmacotherapy, 7(6), pp. 829-832.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) Is exenatide advancing the treatment of Type 2 diabetes? Expert Opinion on Pharmacotherapy, 7(1), pp. 109-112.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2006) Muraglitazar: beneficial or detrimental in the treatment of Type 2 diabetes? Expert Opinion on Pharmacotherapy, 7(9), pp. 1229-1233.
Number of citations in Scopus 4
Number of citations in Web of Science® 5

Doggrell, Sheila (2006) Natalizumab in multiple sclerosis: proceed with caution? Expert Opinion on Pharmacotherapy, 7(12), pp. 1675-1678.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) New targets in and potential treatments for cholesterol gallstone disease. Current Opinion in Investigational Drugs, 7(4), pp. 344-348.
Number of citations in Scopus 8
Number of citations in Web of Science® 5

Doggrell, Sheila (2006) Nitrone spin on cerebral ischemia. Current Opinion in Investigational Drugs, 7(1), pp. 20-24.
Number of citations in Scopus 4
Number of citations in Web of Science® 4

Doggrell, Sheila (2006) Partial agonism at nicotinic receptors with varenicline - a new approach to smoking cessation. Expert Opinion on Pharmacotherapy, 7(18), pp. 2599-2603.
Number of citations in Scopus 1

Doggrell, Sheila (2006) Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease. Expert Opinion on Pharmacotherapy, 7(4), pp. 485-488.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) Phosphoinositide 3-kinase-gamma as a target in rheumatoid arthritis and systemic lupus. Expert Opinion on Therapeutic Targets, 10(4), pp. 627-630.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) Recent evidence of sustained benefit with exenatide in Type 2 diabetes. Expert Opinion on Pharmacotherapy, 7(14), pp. 2003-2006.
Number of citations in Scopus 6
Number of citations in Web of Science® 6

Doggrell, Sheila (2006) Sibutramine for obesity in adolescents. Expert Opinion on Pharmacotherapy, 7(17), pp. 2435-2438.
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila (2006) 'Simply stunning' - trastuzumab in HER2-positive breast cancer. Expert Opinion on Pharmacotherapy, 7(5), pp. 631-634.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2006) Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation. Expert Opinion on Pharmacotherapy, 7(2), pp. 225-228.
Number of citations in Scopus 2

Doggrell, Sheila (2006) Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention? Expert Opinion on Pharmacotherapy, 7(15), pp. 2169-2173.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) Aspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleeding. Expert Opinion on Pharmacotherapy, 6(7), pp. 1253-1256.
Number of citations in Scopus 6
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) BG-9928 (Biogen Idec). Current Opinion in Investigational Drugs, 6(9), pp. 962-968.
Number of citations in Scopus 9

Doggrell, Sheila (2005) BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia. Expert Opinion on Investigational Drugs, 14(1), pp. 89-91.
Number of citations in Scopus 29
Number of citations in Web of Science® 25

Doggrell, Sheila (2005) Berberine - a novel approach to cholesterol lowering. Expert Opinion on Investigational Drugs, 14(5), pp. 683-685.
Number of citations in Scopus 27
Number of citations in Web of Science® 25

Doggrell, Sheila (2005) Bradykinin B2 receptors - a target in diabetic nephropathy. Expert Opinion on Therapeutic Targets, 9(2), pp. 411-414.
Number of citations in Scopus 5
Number of citations in Web of Science® 5

Doggrell, Sheila (2005) CHARMed - the effects of candesartan in heart failure. Expert Opinion on Pharmacotherapy, 6(3), pp. 513-516.
Number of citations in Scopus 2

Doggrell, Sheila (2005) CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction. Expert Opinion on Pharmacotherapy, 6(10), pp. 1761-1764.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) Calmodulin kinase II as a target for inhibition in cardiac disease. Expert Opinion on Therapeutic Targets, 9(6), pp. 1319-1321.

Doggrell, Sheila & Wanstall, Janet (2005) Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors. Canadian Journal of Physiology and Pharmacology, 83(2), pp. 123-130.
Number of citations in Scopus 30
Number of citations in Web of Science® 22

Doggrell, Sheila (2005) Clinical evidence for drug treatments in obesity in hypertensive patients. Methods and Findings in Experimental and Clinical Pharmacology, 27(2), pp. 119-125.
Number of citations in Scopus 4
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Clinical potential of nitric oxide-independent soluble guanylate cyclase activators. Current Opinion in Investigational Drugs, 6(9), pp. 874-878.
Number of citations in Scopus 11

Doggrell, Sheila (2005) Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction. Expert Opinion on Pharmacotherapy, 6(1), pp. 75-84.
Number of citations in Scopus 30
Number of citations in Web of Science® 23

Doggrell, Sheila (2005) Conivaptan (Yamanouchi). Current Opinion in Investigational Drugs, 6(3), pp. 317-326.
Number of citations in Scopus 7

Doggrell, Sheila (2005) Cytochrome P-450: a new target in the heart and coronary circulation. Drugs of the Future, 30(3), pp. 261-269.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Wanstall, Janet, Homer, Kerry, & Doggrell, Sheila (2005) Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Current Vascular Pharmacology, 3(1), pp. 41-53.
Number of citations in Scopus 50

Doggrell, Sheila (2005) Farnesoid X receptor agonism - a new approach to the treatment of cholesterol gallstone disease. Expert Opinion on Investigational Drugs, 14(4), pp. 535-538.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2005) Fluoxetine - do the benefits outweigh the risks in adolescent major depression? Expert Opinion on Pharmacotherapy, 6(1), pp. 147-150.
Number of citations in Scopus 6
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved? Expert Opinion on Pharmacotherapy, 6(5), pp. 831-834.
Number of citations in Scopus 5
Number of citations in Web of Science® 1

Doggrell, Sheila & Hancox, Jules (2005) Ibutilide - recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert Opinion on Investigational Drugs, 14(5), pp. 655-669.
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) Is AMN-107 a step forward from imatinib in the treatment of chronic myeloid leukaemia? Expert Opinion on Investigational Drugs, 14(8), pp. 1063-1066.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity? Expert Opinion on Pharmacotherapy, 6(12), pp. 2141-2144.

Doggrell, Sheila (2005) More support for high-dose atorvastatin in coronary artery disease. Expert Opinion on Pharmacotherapy, 6(13), pp. 2365-2368.

Doggrell, Sheila (2005) NF-(kappa)B - a target in the inflammation of bone destruction. Expert Opinion on Therapeutic Targets, 9(1), pp. 191-193.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2005) Neuromedin U - a new target in obesity. Expert Opinion on Therapeutic Targets, 9(4), pp. 875-877.
Number of citations in Scopus 7
Number of citations in Web of Science® 5

Doggrell, Sheila (2005) New drugs being developed for the treatment of tuberculosis. Expert Opinion on Investigational Drugs, 14(7), pp. 917-920.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration. Expert Opinion on Pharmacotherapy, 6(8), pp. 1421-1423.
Number of citations in Scopus 32
Number of citations in Web of Science® 27

Doggrell, Sheila (2005) Phosphodiesterase 5A as a target in cardiac disease. Expert Opinion on Therapeutic Targets, 9(5), pp. 1097-1100.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2005) Potential of growth hormone-releasing hormone antagonists (JV-1-36 and JV-1-42) for the treatment of brain tumours. Expert Opinion on Investigational Drugs, 14(12), pp. 1561-1564.

Doggrell, Sheila (2005) Pregabalin or morphine and gabapentin for neuropathic pain. Expert Opinion on Pharmacotherapy, 6(14), pp. 2535-2539.
Number of citations in Scopus 6
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Recent findings with docetaxel in postoperative treatment for breast cancer. Expert Opinion on Pharmacotherapy, 6(16), pp. 2903-2906.

Doggrell, Sheila (2005) Recent important trials of pharmacotherapy in Parkinson's disease. Expert Opinion on Pharmacotherapy, 6(6), pp. 1025-1028.

Doggrell, Sheila (2005) Relating statin therapy to C-reactive protein levels. Expert Opinion on Pharmacotherapy, 6(9), pp. 1597-1600.
Number of citations in Scopus 7
Number of citations in Web of Science® 7

Doggrell, Sheila (2005) Rho-kinase inhibitors show promise in pulmonary hypertension. Expert Opinion on Investigational Drugs, 14(9), pp. 1157-1159.
Number of citations in Scopus 19
Number of citations in Web of Science® 15

Doggrell, Sheila (2005) Stabilisation of calstabin2 - a new approach in sudden cardiac death. Expert Opinion on Therapeutic Targets, 9(5), pp. 955-962.
Number of citations in Scopus 4
Number of citations in Web of Science® 3

Doggrell, Sheila (2005) Taking the 20-HETE out of the cardiovascular system: The potential of 20-HETE synthesis inhibitors. Current Opinion in Investigational Drugs, 6(9), pp. 901-906.
Number of citations in Scopus 2

Doggrell, Sheila (2005) Which drug combination for hormone-refractory prostate cancer? Expert Opinion on Pharmacotherapy, 6(4), pp. 667-670.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2005) Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant? Expert Opinion on Investigational Drugs, 14(3), pp. 339-342.
Number of citations in Scopus 12
Number of citations in Web of Science® 7

Doggrell, Sheila (2005) Ximelagatran - recent comparisons with warfarin. Expert Opinion on Pharmacotherapy, 6(11), pp. 1943-1946.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2005) The nitrosterols - a step forward from the steroid anti-inflammatory drugs? Expert Opinion on Investigational Drugs, 14(7), pp. 823-828.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) The safety of lumiracoxib when used in the treatment of arthritis. Expert Opinion on Pharmacotherapy, 6(2), pp. 347-350.
Number of citations in Scopus 8
Number of citations in Web of Science® 7

Doggrell, Sheila (2005) A small-molecule lead compound for the treatment of Alzheimer's disease. Expert Opinion on Investigational Drugs, 14(2), pp. 199-201.

Conference Paper

Schaffer, Sally, Doggrell, Sheila, & Polkinghorne, Adam (2013) Continuing success of a strategy to support accelerated nursing students at two diverse campuses. In First Year Higher Education (FYHE 2013), 7-10 July 2013, Museum of New Zealand Te Papa Tongarewa, Wellington.
Number of full-text downloads 14

Doggrell, Sheila A. (2012) Writing eBooks to support first year students. In First Year in Higher Education Conference, 6 July 2007, Queensland University of Technology, Brisbane, Queensland, Australia.
Number of full-text downloads 69

Doggrell, Sheila A. & Polkinghorne, Adam (2011) A Strategy for supporting students given Advanced Standing into Nursing. In Thomas, Jason (Ed.) 14th Pacific Rim First Year in Higher Education Conference 2011 : Design for Student Success, Colourwise Reproductions, Freemantle, Western Australia.
Number of full-text downloads 15

Conference Item

Schaffer, Sally, Doggrell, Sheila, Polkinghorne, Adam, & Tuli, Rinku (2014) A loss of bioscience knowledge in nursing students. In ANZAHPE 2014 Annual Conference of the Australian and New Zealand Association for Health Professional Educators, 7-10 July 2014, Gold Coast, Australia. (Unpublished)
Number of full-text downloads 4

Doggrell, Sheila, Schaffer, Sally, Polkinghorne, Adam, & Tuli, Rinku (2014) Do nursing students have the recall of bioscience necessary to study pharmacology? In 17th World Congress of Basic and Clinical Pharmacology (WCP2014), 13-18 July 2014, Cape Town, South Africa.

Doggrell, Sheila A., Schaffer, Sally, & Polkinghorne, Adam (2013) Surviving Bioscience and Pharmacology – an eBook for accelerated students in Nursing. In 16th International First Year Higher Education Conference 2013, 7-10 July 2013, Museum of New Zealand Te Papa Tongarewa, Wellington, New Zealand.
Number of full-text downloads 62

Doggrell, Sheila Anne, Schaffer, Sally, & Dallemagne, Catherine (2012) Transferring a successful strategy for supporting accelerated nursing students from a small to a large cohort. In Nelson, Karen J. & Kift, Sally M. (Eds.) 15th International First Year in Higher Education Conference : New Horizons, 26-29 June 2012, Sofitel Brisbane Central, Brisbane, QLD.
Number of full-text downloads 49

Polkinghorne, Adam & Doggrell, Sheila (2012) A successful strategy for supporting low socioeconomic and accelerated students studying Biosciences in their first year of study. In Mortimer, Rachel (Ed.) 15th International First Year in Higher Education Conference 2012 : New Horizons, 26 - 29 June 2012, Sofitel Brisbane Central, Brisbane, Queensland, Australia.
Number of full-text downloads 24

Review

Doggrell, Sheila A. (2012) More light at the end of the tunnel – apixaban in atrial fibrillation. Expert Opinion in Investigational Drugs, 21(8), pp. 1235-1239.
Number of full-text downloads 91
Number of citations in Scopus 1

Doggrell, Sheila & Hancox, Jules (2012) PALLAS : limiting indications for dronedarone treatment of atrial fibrillation. Expert Opinion on Pharmacotherapy, 13(6), pp. 867-871.
Number of full-text downloads 22
Number of citations in Web of Science® 1

Doggrell, Sheila (2012) The ezetimibe controversy? Can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together? Expert Opinion on Pharmacotherapy, 13(10), pp. 1469-1480.
Number of full-text downloads 101
Number of citations in Scopus 7
Number of citations in Web of Science® 9

Other

Doggrell, Sheila (2012) Drugs and local chemical mediators. Pharmacology in One Semester.
Number of full-text downloads 72

Doggrell, Sheila (2012) Drugs and neurotransmitters. Pharmacology in One Semester.
Number of full-text downloads 88

Doggrell, Sheila (2012) Drugs and the gastrointestinal tract. Pharmacology in One Semester. (Unpublished)
Number of full-text downloads 146

Doggrell, Sheila (2012) Drugs and the somatic nervous system. Pharmacology in One Semester.
Number of full-text downloads 42

Doggrell, Sheila (2012) Drugs for cardiac arrhythmmias, antithrombotic drugs and lipid modulating drugs. Pharmacology in one semester.
Number of full-text downloads 48

Doggrell, Sheila (2012) Drugs for diabetes and obesity. Pharmacology in one semester.
Number of full-text downloads 60

Doggrell, Sheila (2012) Drugs for hypertension, angina and heart failure. Pharmacology in One Semester.
Number of full-text downloads 147

This list was generated on Fri Dec 19 16:46:14 2014 AEST.